Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EBOS GROUP LIMITED Interim / Quarterly Report 2014

Feb 18, 2014

64813_rns_2014-02-18_32428acd-2cd5-4eb0-b45d-5101537a129e.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

==> picture [277 x 154] intentionally omitted <==

----- Start of picture text -----

EBOS GROUP LIMITED
INTERIM REPORT
2014
----- End of picture text -----

EBOS GROUP LIMITED
INTERIM REPORT 2014
CONTENTS Page
Summary of Financial Highlights 1
Shareholder Calendar 1
Auditor’s Report 2
Condensed Consolidated Income Statement 3
Condensed Consolidated Statement of Comprehensive Income 4
Condensed Consolidated Statement of Changes in Equity 4
Condensed Consolidated Balance Sheet 5
Condensed Consolidated Cash Flow Statement 6
Notes to the Interim Financial Statements 7
Directory 19

EBOS GROUP LIMITED INTERIM REPORT 2014 SUMMARY OF FINANCIAL HIGHLIGHTS

Six months
31 Dec 13
$’000
(Unaudited)
Six months
31 Dec 12
$’000
(Unaudited)
Year ended
30 Jun 13
$’000
Audited
Revenue
3,001,512
755,250
EBITDA
96,247
27,230
Profit before income tax expense
69,347
20,828
Profit for the period
49,409
14,959
Shareholders’ interest
961,131
215,903
Earnings per share
34c
25c*
Interest cover
5.5
6.0
Net interest bearing debt to net interest bearing
debt plus equity
26.7%
30.8%
Net asset backing per share
651c
410c
1,823,169
58,243
42,214
28,207
304,877
47c*
5.4
36.3%
465c

‘* Earnings per share for comparative periods has been adjusted for the bonus share element included in the rights issue of 5 July 2013, as required by International Financial Reporting Standards. This is to allow a direct like for like comparison of the current period earnings per share with comparative periods.

SHAREHOLDER CALENDAR

Release of half year result Interim dividend record date Interim dividend payable Release of full year result Final dividend payable Annual General Meeting

19 February 2014 14 March 2014 4 April 2014 Late August 2014 Late October 2014 31 October 2014

1

REVIEW REPORT TO THE SHAREHOLDERS OF EBOS GROUP LIMITED

We have reviewed the condensed consolidated interim financial statements on pages 3 to 18. The condensed consolidated interim financial statements provide information about the past financial performance of the EBOS Group Limited and its financial position as at 31 December 2013. This information is stated in accordance with the accounting policies referred to on page 7.

This report is made solely to the company’s shareholders, as a body. Our review has been undertaken so that we might state to the company’s shareholders those matters we are required to state to them in a review report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company’s shareholders as a body, for our engagement, for this report, or for the opinions we have formed.

Board of Directors’ Responsibilities

The Board of Directors is responsible for the preparation, in accordance with New Zealand law and generally accepted accounting practice, of the condensed consolidated interim financial statements which give a true and fair view of the financial position of the Group as at 31 December 2013 and of the results of operations and cash flows for the six months ended on that date.

Independent Accountant’s Responsibilities

We are responsible for reviewing the condensed consolidated interim financial statements presented by the Board of Directors in order to report to you whether, in our opinion and on the basis of the procedures performed by us, anything has come to our attention that would indicate that the condensed consolidated interim financial statements do not present fairly the matters to which they relate.

Basis of Opinion

A review is limited primarily to enquiries of company personnel and analytical review procedures applied to financial data and thus provide less assurance than an audit. We have not performed an audit and, accordingly, we do not express an audit opinion.

We have reviewed the condensed consolidated interim financial statements of EBOS Group Limited for the six months ended 31 December 2013 in accordance with the Review Engagement Standards issued by the External Reporting Board.

Other than in our capacity as auditors under the Companies Act 1993, the provision of due diligence work, internal control assurance services and other advisory services we have no relationship with or interests in EBOS Group Limited or any of its subsidiaries.

Opinion

Based on our review, which is not an audit, nothing has come to our attention that causes us to believe that the accompanying condensed consolidated interim financial statements on pages 3 to 18 do not present fairly the financial position of the Group as at 31 December 2013 and the results of operations and cash flows for the six months ended on that date in accordance with NZ IAS 34: Interim Financial Reporting and IAS 34: Interim Financial Reporting.

Our review was completed on 18 February 2014 and our review opinion is expressed as at that date.

==> picture [89 x 46] intentionally omitted <==

Chartered Accountants Christchurch, New Zealand

2

EBOS GROUP LIMITED CONDENSED CONSOLIDATED INCOME STATEMENT For the Six Months ended 31 December 2013

Notes
Six months
31 Dec 13
$’000
(Unaudited)
Six months
31 Dec 12
$’000
(Unaudited)
Year ended
30 Jun 13
$’000
(Audited)
Revenue
2(a)
3,001,512
755,250
Profit before depreciation, amortisation,
finance costs and income tax expense
96,247
27,230
Depreciation
2(b)
(5,187)
(2,171)
Amortisation of finite life intangibles
2(b)
(6,162)
(91)
1,823,169
58,243
(4,922)
(1,514)
Profit before finance costs and tax
84,898
24,968
Finance costs
2(b)
(15,551)
(4,140)
51,807
(9,593)
Profit before income tax expense
2(b)
69,347
20,828
Income tax expense
(19,938)
(5,869)
42,214
(14,007)
Profit for theperiod
49,409
14,959
28,207
Earnings per share
Basic (cents per share)
34
25
Diluted (cents per share)
34
25
47
47

Calculated on a weighted average basis of the number of shares on issue.

3

EBOS GROUP LIMITED CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME For the Six Months ended 31 December 2013

Six months
31 Dec 13
$’000
(Unaudited)
Six months
31 Dec 12
$’000
(Unaudited)
Year ended
30 Jun 13
$’000
(Audited)
Profit for the period
49,409
14,959
Other comprehensive income
Items that may be reclassified subsequently to profit or
loss:
Cash flow hedges gains/(losses)
404
(485)
Related income tax
(137)
144
Translation of foreign operations
(20,695)
(329)
28,207
2,773
(359)
(6,365)
Total comprehensive income net of tax
28,981
14,289
24,256

EBOS GROUP LIMITED CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY For the Six Months ended 31 December 2013

Notes
Six months
31 Dec 13
$’000
(Unaudited)
Six months
31 Dec 12
$’000
(Unaudited)
Year ended
30 Jun 13
$’000
(Audited)
Equity at start of period
304,877
208,601
Profit for the period
49,409
14,959
Other comprehensive income:
Movements in cashflow hedge reserve
267
(341)
Movement in foreign currency translation
reserve
(20,695)
(329)
Dividends paid to company shareholders
4
(21,992)
(10,682)
Shares issued
3
649,265
3,695
208,601
28,207
2,414
(6,365)
(21,298)
93,318
Equity at end ofperiod
961,131
215,903
304,877

4

EBOS GROUP LIMITED CONDENSED CONSOLIDATED BALANCE SHEET As at 31 December 2013

Notes
31 Dec 13
$’000
(Unaudited)
31 Dec 12
$’000
(Unaudited)
30 Jun 13
$’000
(Audited)
Current assets
Cash and cash equivalents
92,580
41,782
Trade and other receivables
755,396
178,149
Prepayments
7,269
2,912
Inventories
505,835
162,248
Current tax refundable
1,401
1,575
Other financial assets – derivatives
2,630
35
198,014
736,429
7,837
558,350
1,628
3,546
Total current assets
1,365,111
386,701
1,505,804
Non-current assets
Property, plant and equipment
98,437
22,053
Capital work in progress
693
191
Prepayments
-
348
Deferred tax assets
28,936
6,357
Goodwill
721,046
180,422
Indefinite life intangibles
56,941
30,867
Finite life intangibles
82,067
269
Investment in associates
22,620
18,838
95,131
787
16
34,361
722,158
59,324
95,145
19,013
Total non-current assets
1,010,740
259,345
1,025,935
Total assets
2,375,851
646,046
2,531,739
Current liabilities
Trade and other payables
874,358
263,147
Finance leases
968
411
Bank loans
7
176,560
9,001
Current tax payable
19,615
4,219
Employee benefits
22,460
8,021
Other financial liabilities – derivatives
1,668
870
Deferredpurchase consideration
-
-
892,645
1,189
215,675
6,378
25,725
2,872
865,000
Total current liabilities
1,095,629
285,669
2,009,484
Non-current liabilities
Bank loans
7
262,641
127,273
Trade and other payables
9,605
4,113
Deferred tax liabilities
40,073
10,784
Finance leases
2,566
1,034
Employee benefits
4,206
1,270
151,357
8,489
48,365
3,296
5,871
Total non-current liabilities
319,091
144,474
217,378
Total liabilities
1,414,720
430,143
2,226,862
Net assets
961,131
215,903
304,877
Equity
Share capital
3
850,553
111,665
Foreign currency translation reserve
(26,370)
361
Retained earnings
134,685
104,636
Cash flow hedge reserve
2,263
(759)
201,288
(5,675)
107,268
1,996
Total equity
961,131
215,903
304,877

5

EBOS GROUP LIMITED CONDENSED CONSOLIDATED CASH FLOW STATEMENT For the Six Months ended 31 December 2013

Notes
Six months
31 Dec 13
$’000
(Unaudited)
Six months
31 Dec 12
$’000
(Unaudited)
Year ended
30 Jun 13
$’000
(Audited)
Cash flows from operating activities
Receipts from customers
2,927,400
751,727
Interest received
1,461
446
Payments to suppliers and employees
(2,855,278)
(738,896)
Taxes paid
(8,460)
(8,239)
Interestpaid
(15,551)
(4,140)
1,917,358
1,198
(1,869,090)
(13,458)
(9,593)
Net cash inflow from operating activities
5
49,572
898
Cash flows from investing activities
Sale of property, plant & equipment
476
437
Purchase of property, plant & equipment
(15,485)
(1,129)
Payments for capital work in progress
-
(182)
Payments for intangible assets
(631)
(83)
Acquisition of associates
(2,988)
-
Acquisition of subsidiaries
(366,853)
-
Costs associated with acquisition of
subsidiaries
-
-
26,415
403
(2,943)
(778)
(142)
-
49,263
(5,993)
Net cash (outflow)/inflow from investing
activities
(385,481)
(957)
Cash flows from financing activities
Proceeds from issue of shares
3
151,119
3,695
Proceeds from borrowings
317,716
2,700
Repayment of borrowings
(211,011)
(6,044)
Dividendspaid to equityholders ofparent
4
(21,992)
(10,682)
39,810
93,318
30,009
(21,474)
(21,298)
Net cash inflow/(outflow) from financing
activities
235,832
(10,331)
Net (decrease)/increase in cash held
(100,077)
(10,390)
Effect of exchange rate fluctuations on cash
held
(5,357)
(167)
Net cash and cash equivalents at beginning of
period
198,014
52,339
80,555
146,780
(1,105)
52,339
Net cash and cash equivalents at end of
period
92,580
41,782
198,014
Cash and cash equivalents
92,580
41,782
198,014
92,580
41,782
198,014

6

EBOS GROUP LIMITED NOTES TO THE INTERIM FINANCIAL STATEMENTS For the Six Months ended 31 December 2013

1. FINANCIAL STATEMENTS

These unaudited interim financial statements have been prepared in accordance with Generally Accepted Accounting Practice in New Zealand (“NZ GAAP”). They comply with New Zealand Equivalent to International Accounting Standard 34 (NZ IAS 34) “Interim Financial Reporting” and International Accounting Standard IAS 34, as applicable for profit orientated entities.

The same accounting policies and methods of computation are applied in the interim financial statements as were applied in the financial statements for the year ended 30 June 2013. These financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report for the year ended 30 June 2013. The information is presented in thousands of New Zealand dollars unless otherwise stated.

2. PROFIT FROM OPERATIONS

(a)
(b)
Six months
31 Dec 13
$’000
(Unaudited)
Six months
31 Dec 12
$’000
(Unaudited)
Year ended
30 Jun 13
$’000
(Audited)
Revenue
Revenue from the sale of goods
2,955,281
753,378
Revenue from the rendering of services
44,770
1,308
Management fees
-
118
Interest revenue
1,461
446
1,811,465
10,506
-
1,198
3,001,512
755,250
1,823,169
Profit before income tax expense
Profit before income tax has been arrived
at after crediting/(charging) the following
gains and losses from operations:
Gain on sale of property, plant and
equipment
286
227
Change in fair value of derivative financial
instruments
(115)
79
Share of profits of associates
619
410
Profit before income tax has been arrived
at after (charging) the following expenses
by nature:
Cost of sales
(2,701,778)
(656,945)
Write-down of inventory
(1,550)
(1,280)
Finance costs:
Bank interest
(15,229)
(3,863)
Other interest expense
(322)
(277)
170
257
585
(1,597,475)
(2,227)
(8,979)
(614)
Total finance costs
(15,551)
(4,140)
Net bad and doubtful debts arising from:
Impairment loss on trade & other
receivables
(1,249)
(357)
Depreciation of property, plant & equipment
(5,187)
(2,171)
Amortisation of finite life intangibles
(6,162)
(91)
Operating lease rental expenses:
Minimum lease payments
(12,993)
(4,788)
Donations
(41)
(30)
Employee benefit expense
(97,585)
(33,750)
Defined contribution plan expenses
(5,576)
(1,259)
Costs associated with acquisition of
subsidiaries
-
-
Other expenses
(85,283)
(30,327)
(9,593)
(14)
(4,922)
(1,514)
(9,227)
(29)
(76,213)
(2,927)
(5,993)
(71,833)
Total expenses
(2,932,955)
(735,138)
(1,781,967)
Profit before income tax expense
69,347
20,828
42,214

7

EBOS GROUP LIMITED NOTES TO THE INTERIM FINANCIAL STATEMENTS (Continued) For the Six Months ended 31 December 2013

3.
4.
SHARE CAPITAL
Six months
31 Dec 13
(Unaudited)
Six months
31 Dec 12
(Unaudited)
No.
’000
Total
$’000
No.
’000
Total
$’000
SHARE CAPITAL
Six months
31 Dec 13
(Unaudited)
Six months
31 Dec 12
(Unaudited)
No.
’000
Total
$’000
No.
’000
Total
$’000
Year ended
30 Jun 13
(Audited)
No.
’000
Total
$’000
Fully paid ordinary
shares
Balance at beginning of
period
65,546
201,288
52,107
107,970
Dividend re-invested –
October 2012
-
-
429
3,445
April 2013
-
-
-
-
October 2013
996
9,500
-
-
Bonus issue – June 2013
-
-
-
-
Institutional placement –
June 2013
-
-
-
-
Share issue costs
-
-
-
-
Rights issue - July 2013
Share issue costs
Issue of consideration
shares – July 2013
Share issue costs
22,941
-
58,127
-
149,119
(7,356)
498,146
(144)
-
-
-
-
-
-
-
-
Issue of shares to
executives and staff under
employee share
ownershipscheme
-
-
63
250
52,107
107,970
429
3,445
357
3,100
-
-
1,999
-
10,591
90,026
-
(3,503)
-
-
-
-
-
-
-
-
63
250
147,610
850,553
52,599
111,665
DIVIDENDS
Six months
31 Dec 13
(Unaudited)
Six months
31 Dec 12
(Unaudited)
Cents
per
share
Total
$’000
Cents
per
share
Total
$’000
65,546
201,288
Year ended
30 Jun 13
(Audited)
Cents
per
share
Total
$’000
Recognised amounts
Fully paid ordinary shares
- Final – prior year
15.0
21,992
20.5
10,682
- Taxable bonus issue
-
-
-
-
- Interim – currentyear
-
-
-
-
20.5
10,682
-
1,411
17.5
9,205
15.0
21,992
20.5
10,682
Unrecognised amounts
Final dividend
-
-
-
-
Interim dividend
20.5
30,260
17.5
9,205
38.0
21,298
15.0
21,992
-
-
20.5
30,260
17.5
9,205
15.0
21,992

The Board approved an interim dividend of 20.5 cents per share on 18 February 2014. The record date for the dividend is 14 March 2014 and the dividend will be paid on 4 April 2014. The Group’s dividend reinvestment plan will be operable for this interim dividend.

8

EBOS GROUP LIMITED NOTES TO THE INTERIM FINANCIAL STATEMENTS (Continued) For the Six Months ended 31 December 2013

5. NOTES TO THE CASH FLOW STATEMENT

Six months
31 Dec 13
$’000
(Unaudited)
Six months
31 Dec 12
$’000
(Unaudited)
Year ended
30 Jun 13
$’000
(Audited)
Reconciliation of profit for the period with cash
flows from operating activities
Profit for the period
49,409
14,959
Add/(less) non-cash items:
Depreciation
5,187
2,171
Gain on sale of property, plant & equipment
(286)
(227)
Share of profits of associates
(619)
(410)
Amortisation of finite life intangibles
6,162
91
Loss/(gain) on derivatives/financial instruments
115
(79)
Deferred tax
(2,901)
1,264
Provision for doubtful debts
(156)
(125)
28,207
4,922
(170)
(585)
1,514
(257)
12
(441)
7,502
2,685
4,995
Movements in working capital:
Trade and other receivables
(18,811)
(2,312)
Prepayments
584
1,475
Inventories
52,515
749
Current tax refundable/payable
13,464
(3,609)
Trade and other payables
(17,171)
(12,231)
Employee benefits
(4,930)
(473)
Foreign currency translation of opening working
capital balances
(32,990)
(345)
(560,276)
(3,118)
(395,353)
(1,503)
621,643
21,832
(6,421)
(7,339)
(16,746)
(323,196)
Cash costs classified as investing activities:
Costs associated with acquisition of subsidiaries
-
-
Working capital items acquired
-
-
5,993
310,416
Net cash inflow from operating activities
49,572
898
26,415

9

EBOS GROUP LIMITED NOTES TO THE INTERIM FINANCIAL STATEMENTS (Continued) For the Six Months ended 31 December 2013

6. SEGMENT INFORMATION

(a) Products and services from which reportable segments derive their revenues The Group’s reportable segments are:

Healthcare: Incorporates the sale of human healthcare products in a range of sectors, own brands, retail healthcare and wholesale activities.

Animal care: Incorporates the sale of animal care products in a range of sectors, own brands, retail and wholesale activities.

Corporate: Includes net funding costs and parent company central administration expenses that have not been allocated to the healthcare or animal care segments.

(b) Segment revenues and results

The following is an analysis of the Group’s revenue and results by reportable segment:

Six months
31 Dec 13
$’000
(Unaudited)
Six months
31 Dec 12
$’000
(Unaudited)
Year ended
30 Jun 13
$’000
(Audited)
Revenue from external customers
Healthcare
Animal care
Corporate
Segment result
Healthcare
Animal care
Corporate
Segment expenses
Healthcare:
Depreciation
Amortisation of finite life intangibles
Income tax expense
Animal care:
Depreciation
Amortisation of finite life intangibles
Income tax expense
Corporate:
Finance costs
Income tax credit
Profit for the period
Healthcare
Animal care
Corporate
2,823,018
177,033
1,461
81,922
15,720
(1,395)
(4,439)
(5,139)
(20,133)
(748)
(1,023)
(4,402)
(15,551)
4,597
52,211
9,547
(12,349)
49,409
673,312
81,492
446
19,573
9,378
(1,721)
(1,622)
(15)
(5,116)
(549)
(76)
(2,395)
(4,140)
1,642
12,820
6,358
(4,219)
14,959
1,652,450
169,521
1,198
49,068
18,670
(9,495)
(3,785)
(1,194)
(13,146)
(1,137)
(320)
(4,588)
(9,593)
3,727
30,943
12,625
(15,361)

28,207
  • Includes costs associated with the acquisition of subsidiaries of $5.993m.

10

EBOS GROUP LIMITED NOTES TO THE INTERIM FINANCIAL STATEMENTS (Continued) For the Six Months ended 31 December 2013

6. SEGMENT INFORMATION (Continued)

The accounting policies of the reportable segments are consistent with the Group’s accounting policies. Segment result represents profit before depreciation, amortisation, finance costs and tax. This is the measure reported to the chief operating decision maker for the purposes of resource allocation and assessment of segment performance.

(c) Segment assets

The following balance sheet items are not allocated to operating segments as they are not reported to the chief operating decision maker at a segment level:

  • Assets

  • Liabilities

  • Capital expenditure

(d) Revenues from major products and services

The Group’s major products and services are the same as its reportable segments i.e. healthcare, and animal care, and corporate.

(e) Geographical information

The Group operates in two principal geographical areas; New Zealand (country of domicile) and Australia.

The Group’s revenue from external customers by geographical location (of the reportable segment) and information about its segment assets (non-current assets excluding financial instruments and deferred tax assets are detailed below):

Six months
31 Dec 13
$’000
(Unaudited)
Six months
31 Dec 12
$’000
(Unaudited)
Year ended
30 Jun 13
$’000
(Audited)
Revenue from external customers
New Zealand
650,064
642,183
Australia
2,351,448
113,067
1,257,302
565,867
3,001,512
755,250
Non-current assets
New Zealand
207,002
207,464
Australia
752,182
26,686
1,823,169
206,945
765,616
959,184
234,150
972,561

(f) Information about major customers

No revenues from transactions with a single customer amount to 10% or more of the Group’s revenues (December 2012: Nil, June 2013: Nil).

7. BANK FACILITY AND BORROWINGS

The Group fully complies with and operates within the financial covenants under the arrangements with its bankers. At 31 December 2013 the Group has unutilised term and revolving cash advance facilities of $79.8m (December 2012: $68m, June 2013: $69.5m).

The Group also has a trade debtor securitisation facility of which $310m was unutilised at 31 December 2013 (December 2012: Nil, June 2013: $302.8m).

11

EBOS GROUP LIMITED NOTES TO THE INTERIM FINANCIAL STATEMENTS (Continued) For the Six Months ended 31 December 2013

7. BANK FACILITY AND BORROWINGS (Continued)

On 5 July 2013 the Group refinanced its syndicated banking facilities. The effect of this refinancing was to retain the facility head room that was in place at 30 June 2013 in addition to funding the settlement of the acquisition of the Symbion Group on 5 July 2013. This refinancing also extended the maturity profile of the Group’s borrowing facilities. The Group is committed to repayments of its term debt facilities of approximately $20m per year with quarterly repayment terms.

The Groups new facilities are summarised below:






Facility
Term debt facilities
Term debt facilities
Term debt facilities
Working capital facilities
Securitisation facility
Amount (NZD)
$85.6m
$95.1m
$101.1m
$90.9m
$456.3m
Maturity
July 2015
July 2016
July 2017
July 2015
September 2015

8. SIGNIFICANT TRANSACTIONS DURING THE PERIOD

On 4 July 2013 EBOS Group Limited received a net $141.8m in proceeds from a non re-nounceable rights issue to existing shareholders.

On 5 July 2013, in accordance with the sale and purchase agreement to purchase the Symbion Group, the full deferred consideration payable balance of $865m was settled in favour of the previous owners of the Symbion Group, Zuellig Group. This consideration was made through an issue of EBOS Group Limited shares to the Zuellig Group of $498m and cash consideration of $367m. The cash consideration paid was funded by additional debt funding of $134m and cash reserves.

As a result of this transaction the Zuellig Group holds 40% of the shares in EBOS Group Limited. Also on the 5 July 2013 two new Directors, Peter Williams and Stuart McGregor, were appointed to the Board of EBOS Group Limited and represent the Zuellig Group.

In addition to the above in December 2013 EBOS Group Limited was also registered on the Australian Stock Exchange along with its continuing listing on the New Zealand Exchange.

9. RELATED PARTY DISCLOSURES

EBOS Group Limited is the immediate parent, ultimate parent and controlling party.

At 30 June 2013 ZHHA Pty Limited, a subsidiary of EBOS Group Limited, owed CB Norwood Pty Limited, a subsidiary of the Zuellig Group, $7.230m and Zuellig Group Incorporated $1.856m. These balances were repaid during the period.

As at 31 December 2013 no balances were owing to related parties of EBOS Group.

No amounts owed to related parties have been written off or forgiven during the period.

10. EVENTS AFTER BALANCE DATE

Subsequent to 31 December 2013 the Board have approved an interim dividend to shareholders. For further details please refer to note 4.

12

EBOS GROUP LIMITED NOTES TO THE INTERIM FINANCIAL STATEMENTS (Continued) For the Six Months ended 31 December 2013

11. PROSPECTIVE FINANCIAL INFORMATION

The EBOS Group Limited pro-rata renounceable entitlement offer prospectus issued on 5 June 2013 contained prospective financial information (PFI) for the six month period ended 31 December 2013.

The following information is a comparison of the financial statements of EBOS Group Limited from the prospectus dated 5 June 2013 with the actual result for the same period for the six months ended 31 December 2013.

EBOS GROUP LIMITED CONDENSED CONSOLIDATED INCOME STATEMENT For the Six Months ended 31 December 2013

EBOS GROUP LIMITED
CONDENSED CONSOLIDATED INCOME STATEMENT
For the Six Months ended 31 December 2013
Actual
$M
(Unaudited)
Adjusted
PFI(1)
$M
(Unaudited)
Original
PFI
$M
(Unaudited)
Revenue
3,001.5
2,980.7
Profit before depreciation, amortisation,
finance costs and income tax expense
96.2
97.3
Depreciation
(5.2)
(6.7)
Amortisation of finite life intangibles
(6.1)
(7.8)
3,169.6
103.6
(7.1)
(8.5)
Profit before finance costs and tax
84.9
82.8
Finance costs
(15.6)
(17.3)
88.0
(18.4)
Profit before income tax expense
69.3
65.5
Income tax expense
(19.9)
(19.7)
69.6
(20.9)
Profit for theperiod
49.4
45.8
48.7

EBOS GROUP LIMITED CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME For the Six Months ended 31 December 2013 (unaudited)

EBOS GROUP LIMITED
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
For the Six Months ended 31 December 2013 (unaudited)
Actual
$M
(Unaudited)
Adjusted
PFI(1)
$M
(Unaudited)
Original
PFI
$M
(Unaudited)
Profit for the period
49.4
45.8
Other comprehensive income
Items that may be reclassified subsequently to profit or
loss:
Cash flow hedges gains
0.4
-
Related income tax
(0.1)
-
Translation of foreign operations*
(20.7)
(25.4)
48.7
-
-
-
Total comprehensive income net of tax
29.0
20.4
48.7
  • Represents non-profit foreign currency exchange movements arising from the conversion of the Group’s Australian dollar balance sheet items into the Group’s financial reporting presentation currency, being New Zealand dollars.

(1) The original PFI was determined on an assumed NZD:AUD exchange rate of 0.82:1 for the purpose of converting the Group’s Australian dollar denominated trading results, cashflows and balance sheet. To better understand the underlying performance of the Group the original PFI has been restated using the actual exchange rates that have eventuated on which actual results to 31 December 2013 have been recognised.

13

EBOS GROUP LIMITED NOTES TO THE INTERIM FINANCIAL STATEMENTS (Continued) For the Six Months ended 31 December 2013

11. PROSPECTIVE FINANCIAL INFORMATION (Continued)

EBOS GROUP LIMITED

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY For the Six Months ended 31 December 2013

Actual
$M
(Unaudited)
Adjusted
PFI(1)
$M
(Unaudited)
Original
PFI
$M
(Unaudited)
Equity at start of period
304.9
301.7
Profit for the period
49.4
45.8
Other comprehensive income:
Movements in cashflow hedge reserve
0.3
-
Movement in foreign currency translation
reserve
(20.7)
(25.4)
Dividends paid to company shareholders
(22.0)
(22.0)
Shares issued
649.2
646.3
305.3
48.7
-
-
(22.0)
646.3
Equity at end ofperiod
961.1
946.4
978.3

14

EBOS GROUP LIMITED NOTES TO THE INTERIM FINANCIAL STATEMENTS (Continued) For the Six Months ended 31 December 2013

11. PROSPECTIVE FINANCIAL INFORMATION (Continued)

EBOS GROUP LIMITED
CONDENSED CONSOLIDATED BALANCE SHEET
As at 31 December 2013
Actual
$M
(Unaudited)
Adjusted
PFI(1)
$M
(Unaudited)
Original
PFI
$M
(Unaudited)
Current assets
Cash and cash equivalents
92.6
55.1
Trade and other receivables
755.4
761.9
Prepayments
7.3
7.6
Inventories
505.8
483.3
Current tax refundable
1.4
-
Other financial assets – derivatives
2.6
-
Investments
-
48.9
74.9
832.0
8.2
521.8
-
-
54.8
Total current assets
1,365.1
1,356.8
1,491.7
Non-current assets
Property, plant and equipment
98.4
86.5
Capital work in progress
0.7
-
Prepayments
-
-
Deferred tax assets
28.9
9.6
Goodwill
721.0
736.1
Indefinite life intangibles
56.9
30.8
Finite life intangibles
82.1
122.6
Investment in associates
22.6
19.5
94.6
-
0.2
10.2
729.2
30.8
137.6
19.5
Total non-current assets
1,010.7
1,005.1
1,022.1
Total assets
2,375.8
2,361.9
2,513.8
Current liabilities
Trade and other payables
874.4
845.0
Finance leases
1.0
0.3
Bank loans
176.6
188.7
Current tax payable
19.6
14.3
Employee benefits
22.5
19.8
Other financial liabilities – derivatives
1.6
0.9
913.6
0.3
211.3
16.2
21.3
0.9
Total current liabilities
1,095.7
1,069.0
1,163.6
Non-current liabilities
Bank loans
262.6
280.6
Trade and other payables
9.6
16.4
Deferred tax liabilities
40.1
43.4
Finance leases
2.5
0.9
Employee benefits
4.2
5.2
300.0
17.9
47.4
0.9
5.7
Total non-current liabilities
319.0
346.5
371.9
Total liabilities
1,414.7
1,415.5
1,535.5
Net assets
961.1
946.4
978.3
Equity
Share capital
850.6
849.2
Foreign currency translation reserve
(26.4)
(30.1)
Retained earnings
134.7
127.6
Other reserves
-
0.5
Cash flow hedge reserve
2.2
(0.8)
849.2

(1.3)
130.8
0.5
(0.9)
Total non-current liabilities
961.1
946.4
978.3
15

EBOS GROUP LIMITED NOTES TO THE INTERIM FINANCIAL STATEMENTS (Continued) For the Six Months ended 31 December 2013

11. PROSPECTIVE FINANCIAL INFORMATION (Continued)

EBOS GROUP LIMITED CONDENSED CONSOLIDATED CASH FLOW STATEMENT For the Six Months ended 31 December 2013 (unaudited)

EBOS GROUP LIMITED
CONDENSED CONSOLIDATED CASH FLOW STATEMENT
For the Six Months ended 31 December 2013 (unaudited)
Actual
$M
(Unaudited)
Adjusted
PFI(1)
$M
(Unaudited)
Original
PFI
$M
(Unaudited)
Cash flows from operating activities
Receipts from customers
2,927.4
2,929.0
Interest received
1.5
0.4
Payments to suppliers and employees
(2,855.3)
(2,856.8)
Taxes paid
(8.4)
(16.9)
Interestpaid
(15.6)
(17.3)
3,113.1
0.4
(3,035.0)
(17.4)
(18.4)
Net cash inflow from operating activities
49.6
38.4
Cash flows from investing activities
Sale of property, plant & equipment
0.5
-
Purchase of property, plant & equipment
(15.5)
(13.4)
Payments for intangible assets
(0.6)
-
Acquisition of associates
(3.0)
-
Acquisition of subsidiaries
(366.9)
(369.3)
42.7
-
(14.6)
-
-
(369.3)
Net cash (outflow) from investing
activities
(385.5)
(382.7)
Cash flows from financing activities
Proceeds from issue of shares
151.1
148.1
Increase of investment in Class B Note
-
(4.8)
Proceeds from borrowings
317.8
134.3
Repayment of borrowings
(211.0)
(26.9)
Dividendspaid to equityholders ofparent
(22.0)
(22.0)
(383.9)
148.2
(5.3)
140.0
(19.2)
(22.0)
Net cash inflow from financing activities
235.9
228.7
Net (decrease) in cash held
(100.0)
(115.6)
Effect of exchange rate fluctuations on cash
held
(5.4)
(2.6)
Net cash and cash equivalents at beginning
ofperiod
198.0
173.3
241.7
(99.5)
-
174.4
Net cash and cash equivalents at end of
period
92.6
55.1
74.9
Cash and cash equivalents
92.6
55.1
74.9
92.6
55.1
74.9

16

EBOS GROUP LIMITED NOTES TO THE INTERIM FINANCIAL STATEMENTS (Continued) For the Six Months ended 31 December 2013

11. PROSPECTIVE FINANCIAL INFORMATION (Continued)

The material reasons for the differences between the ‘adjusted’ prospective financial information (‘adjusted PFI’) and actual figures are as follows:

Condensed Consolidated Income Statement:

Profit before depreciation, amortisation, finance costs and tax of $96.2m was consistent with the $97.3m forecast in the adjusted PFI.

Depreciation ($1.5m) and amortisation ($1.7m) were down on adjusted PFI due to less depreciable property, plant and equipment and finite life intangible assets being acquired at the time of acquisition than were forecast in the adjusted PFI.

Finance costs were down $1.7m on adjusted PFI due to a lower than forecast net debt balance and a lower bank funding margin being negotiated under the Groups new syndicated banking facility agreement entered into on 5 July 2013.

The above movements have resulted in NPAT for the six months to December 2013 being $3.6m higher than was forecast in the adjusted PFI.

Condensed Consolidated Balance Sheet:

The Group’s Net Debt position of $346.6m (bank loans offset by cash and cash equivalents and investments) is less than adjusted PFI, $365.3m, by $18.7m. This is primarily due to less cash being tied up in working capital items (receivables $6.5m, trade and other payables $29.4m offset by inventory ($22.5m) due to timing differences for receipts from customers and inventory purchases/payments.

Investments are nil compared to $48.9 in the adjusted PFI. This is as a result of this balance for 31 December 2013 being offset against loans and borrowings as a result of a difference in accounting policies from that used in the preparation of the adjusted PFI. The treatment at 31 December 2013 is consistent with the policy applied in the 30 June 2013 annual financial statements.

Property, plant and equipment is up $11.9m on the adjusted PFI as a result of land and building valuations acquired as part of the Symbion acquisition being higher than forecast in the adjusted PFI.

Deferred tax assets are $19.3m higher compared to the adjusted PFI as a result of additional deferred tax assets being recognised on the acquisition of Symbion than were forecast in the adjusted PFI.

Goodwill is lower than adjusted PFI by $15.1m due to the net assets acquired as part of the acquisition of the Symbion Group, post fair value acquisition adjustments, being higher than was originally forecast in adjusted PFI.

Indefinite life intangible assets are $26.1m higher than adjusted PFI and Finite life intangible assets $40.6m lower than the adjusted PFI due to the finalisation of the valuations of the intangibles acquired as part of the acquisition of the Symbion Group.

17

EBOS GROUP LIMITED NOTES TO THE INTERIM FINANCIAL STATEMENTS (Continued) For the Six Months ended 31 December 2013

11. PROSPECTIVE FINANCIAL INFORMATION (Continued)

Condensed Consolidated Cash Flow Statement:

Net operating cash flows are up $11.2m on adjusted PFI due to less cash being tied up in working capital balances at period end than were anticipated in the adjusted PFI as a result of timing differences for receipts from customers and inventory purchases/payments.

Net investing activity and financing activity cash flows are materially consistent with the PFI.

18

EBOS GROUP LIMITED DIRECTORY

Corporate Head Office

108 Wrights Road P O Box 411 Christchurch 8024 Telephone +64 3 338 0999 Fax +64 3 339 5111 E-mail: [email protected] Internet: www.ebos.co.nz

Directors

Rick Christie Independent Chairman Mark Waller Chief Executive and Managing Director Elizabeth Coutts Independent Director Peter Kraus Stuart McGregor Sarah Ottrey Independent Director Barry Wallace Peter Williams

Senior Executives

Mark Waller Chief Executive Michael Broome Group General Manager – Healthcare Logistics/ProPharma Angus Cooper General Manager – Group Projects/Mergers & Acquisitions Patrick Davies Chief Executive – Symbion Group Dennis Doherty Chief Financial Officer Sean Duggan Chief Executive – Masterpet Group Kelvin Hyland General Manager – EBOS Healthcare New Zealand David Lewis General Manager – EBOS Healthcare Australia Greg Managh Group General Manager – Onelink/MIS

Auditor

Deloitte Christchurch

Bankers

ANZ National Bank Limited Auckland

Bank of New Zealand Christchurch

Solicitor

Chapman Tripp Christchurch

Share Registers

Computershare Investor Services Ltd Computershare Investor Services Pty Ltd Private Bag 92119 GPO Box 3329 Auckland 1142 Melbourne, Victoria 3001 New Zealand Australia Telephone: +64 9 488 8777 Telephone: 1800 501 366

Managing Your Shareholding Online:

To change your address, update your payment instructions and to view your investment portfolio including transactions, please visit: www.computershare.com/investorcentre General enquiries can be directed to:

  • [email protected]

  • Private Bag 92119, Auckland 1142, New Zealand or GPO Box 3329, Melbourne, Victoria 3001, Australia

  • Telephone (NZ) +64 9 488 8777 or (Aust) 1800 501 366

  • Facsimile (NZ) +64 9 488 8787 or (Aust) +61 3 9473 2500

Please assist our registrar by quoting your CSN or shareholder number.

19